Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
3.06 (1y: +128%)
Market Cap 61.9 M P/E(ttm)
Enterprise Value 859.98 M P/B 0.30
WH- NYSE (USA)
WSP Holdings Limited
Not Rated
Top Ranked Predictable Companies
$3.06
Switch to:

WSP Holdings Limited Non-Recurring Items: 0.0 ( as of Dec12)

* All numbers are in millions except for per share data WH 10-Y Financials »

Definition

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company’s reported income drastically.

GuruFocus lists a P/E (NRI), which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Related Terms

Net Income, P/E (NRI)
* All numbers are in millions except for per share data

WSP Holdings Limited Annual Data

This information is for Premium Members Only.


Take the full advantage of Gurus' investment ideas now.

7-Day Free Trial
Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
Non Operating IncomePremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member Only
WSP Holdings Limited Quarterly Data

This information is for Premium Members Only.


Take the full advantage of Gurus' investment ideas now.

7-Day Free Trial
Jun10Sep10Dec10Mar11Jun11Sep11Mar12Jun12Sep12Dec12
Non Operating IncomePremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member OnlyPremium Member Only

Financial Dictionary

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK